approval
saveWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approval
community read0 votes
Sponsor: ASTRAZENECA AB. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalApr 15, 2026 · 172d ago
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalApr 18, 2025 · 534d ago
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalSep 25, 2024 · 739d ago
- approvalWAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalDec 21, 2023 · 1018d ago
same company · ±60 days · 6
- approvalIMFINZI (DURVALUMAB) — FDA approvalNov 25, 2025
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB SULFATE) — FDA approvalNov 19, 2025
- approvalselumetinib sulfate: KOSELUGO (SELUMETINIB) — FDA approvalNov 19, 2025
- approvalcapivasertib: TRUQAP (CAPIVASERTIB) — FDA approvalNov 14, 2025
- recallASTRAZENECA PHARMACEUTICALS recall (Cls II)Oct 22, 2025
- approvalnirsevimab: BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalOct 20, 2025
comments(0)
5-min edit window · permanent after that